Found: 2
Select item for more details and to access through your institution.
Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 6, p. 1, doi. 10.1111/dth.15470
- By:
- Publication type:
- Article
Can secukinumab improve liver fibrosis? A pilot prospective study of 10 psoriatic patients.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 5, p. 1, doi. 10.1111/dth.15065
- By:
- Publication type:
- Article